We are live on
!
Find out more
ICM
IronBridge Capital Management Portfolio holdings
AUM
$1.65B
1-Year Est. Return
18.98%
This Fund
S&P 500
This Quarter
Est. Return
+4.43%
1 Year Est. Return
+18.98%
3 Year Est. Return
+38.35%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$4.09B
AUM Growth
-$510M
(-11%)
Cap. Flow
-$657M
Cap. Flow
% of AUM
-16.07%
Top 10 Holdings %
Top 10 Hldgs %
24.94%
Holding
214
New
16
Increased
20
Reduced
137
Closed
18
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$84.5M |
| 2 |
AbbVie
ABBV
|
+$55.8M |
| 3 |
WLL
Whiting Petroleum Corporation
WLL
|
+$45.2M |
| 4 |
Thermo Fisher Scientific
TMO
|
+$18.3M |
| 5 |
SF
Stifel
SF
|
+$15.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Citigroup
C
|
+$90.8M |
| 2 |
NOV
NOV
|
+$65.1M |
| 3 |
WBA
Walgreens Boots Alliance
WBA
|
+$50.2M |
| 4 |
FEIC
FEI COMPANY
FEIC
|
+$40.5M |
| 5 |
WDR
Waddell & Reed Financial, Inc.
WDR
|
+$40.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.61% |
| 2 | Healthcare | 16.19% |
| 3 | Industrials | 14.55% |
| 4 | Technology | 12.67% |
| 5 | Energy | 9.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
201
Ingredion
INGR
$6.33B
| – | – |
-128,335
| Closed | -$8.74M |
|
|
202
NOV
NOV
$6.93B
| – | – |
-927,635
| Closed | -$65.1M |
|
|
ACH
203
Accendra Health
ACH
$256M
| – | – |
-604,197
| Closed | -$21.2M |
|
|
PRO
204
DELISTED
PROS Holdings
PRO
| – | – |
-147,305
| Closed | -$4.64M |
|
205
PVH
PVH
$4.01B
| – | – |
-74,562
| Closed | -$9.3M |
|
206
Stryker
SYK
$133B
| – | – |
-9,627
| Closed | -$784K |
|
|
ALXN
207
DELISTED
Alexion Pharmaceuticals
ALXN
| – | – |
-2,638
| Closed | -$401K |
|
|
WDR
208
DELISTED
Waddell & Reed Financial, Inc.
WDR
| – | – |
-549,596
| Closed | -$40.5M |
|
|
ATHN
209
DELISTED
Athenahealth, Inc.
ATHN
| – | – |
-27,584
| Closed | -$4.42M |
|
|
FEIC
210
DELISTED
FEI COMPANY
FEIC
| – | – |
-393,060
| Closed | -$40.5M |
|
|
FRX
211
DELISTED
FOREST LABORATORIES INC
FRX
| – | – |
-8,851
| Closed | -$817K |
|
|
VOCS
212
DELISTED
VOCUS INC
VOCS
| – | – |
-319,390
| Closed | -$4.26M |
|
|
ACCL
213
DELISTED
Accelrys Inc
ACCL
| – | – |
-202,327
| Closed | -$2.52M |
|
|
AGN
214
DELISTED
Allergan Inc
AGN
| – | – |
-5,085
| Closed | -$631K |
|
Similar funds
EPCM
AIU
LAM
LT
EMA
BT
CCK
FFEC
IronBridge Capital Management's Q2 2014 Portfolio in Review
As of Q2 2014, IronBridge Capital Management held 214 positions worth $4.09B, down 11% from $4.6B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
IronBridge Capital Management withdrew a net $657M in Q2 2014, closing 18 positions and reducing 137 holdings. Its most notable exit was NOV, an estimated $65.1M position sold in full.
By sector, the portfolio is most concentrated in Financials at 17% of assets, down from 19% a quarter earlier, followed by Healthcare and Industrials.
Against the trend, IronBridge Capital Management opened a new position in AbbVie worth $60.1M.
- IronBridge Capital Management's largest Q2 2014 buy was AbbVie: 1,064,450 shares worth $60.1M.
- IronBridge Capital Management added most to Johnson & Johnson in Q2 2014, an estimated $84.5M increase.
- IronBridge Capital Management's biggest Q2 2014 reduction was Citigroup, cutting an estimated $90.8M.
- IronBridge Capital Management fully exited NOV in Q2 2014, selling an estimated $65.1M.
- IronBridge Capital Management's ten largest holdings make up 25% of its $4.09B portfolio in Q2 2014.
- IronBridge Capital Management opened 16 new positions and closed 18 in Q2 2014.
- IronBridge Capital Management's portfolio value fell 11% quarter-over-quarter to $4.09B.
Based on IronBridge Capital Management's 13F filing for Q2 2014, filed 11 Jul 2014.